AKAN Stock Analysis: Buy, Sell, or Hold?
AKAN - Akanda Corp. Common Shares
$6.20
-0.11 (-1.74%)
▼
5d:
-22.11%
30d:
-55.97%
90d:
-48.76%
WAIT
LOW Confidence
Analysis Updated: Jul 28, 2026 12:00 AM ET
Earnings: Apr 29, 2026
0d
Get Alerted When AKAN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: AKAN is down 22.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: AKAN is down 22.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: AKAN is currently trading at $6.20, which is considered oversold relative to its 30-day fair value range of $8.81 to $15.88.
Technical Outlook: Technically, AKAN is in a uptrend. Immediate support is located at $5.55, while resistance sits at $14.00.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AKAN is in a uptrend. Immediate support is located at $5.55, while resistance sits at $14.00.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$8.81 -
$15.88
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- WARNING: Recommendation downgraded due to -22.1% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$8.81 -
$15.88
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$5.55
Resistance Level
$14.00
Current Trend
Uptrend
Technical data as of
Jul 28, 2026
Fundamental Context
Revenue Growth (YoY)
21.9%
Share & Embed Analysis
Last updated: July 28, 2026 4:23 PM ET
Data refreshes hourly during market hours. Next update: 5:23 PM
Data refreshes hourly during market hours. Next update: 5:23 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AKAN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$202 | 53 HOLD |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$114 | 47 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$112 | 47 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$663 | 48 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 51 HOLD |
